FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020158846> ?p ?o ?g. }

• W2020158846 endingPage "218" @default.
• W2020158846 startingPage "210" @default.
• W2020158846 abstract "Aim: Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are both associated with increased risk for atherosclerotic coronary heart disease (CHD). Thus, it is useful to know the relative efficacy of lipid-altering drugs in these patient populations. Methods: A double-blind, parallel group trial of adult patients with hypercholesterolaemia at high-CHD risk receiving atorvastatin 40 mg/day compared atorvastatin 40 mg plus ezetimibe 10 mg (ezetimibe) vs. doubling atorvastatin to 80 mg. This post hoc analysis reports lipid efficacy results in patients grouped by diagnosis of T2DM, MetS without T2DM or neither. Per cent change from baseline at week 6 was assessed for LDL-C, total cholesterol, HDL-C , non-HDL-C , Apo A-I, Apo B and triglycerides. Safety was monitored through clinical and laboratory adverse events (AEs). Results: Compared with doubling atorvastatin, atorvastatin plus ezetimibe resulted in greater reductions in LDL-C, triglycerides, Apo B, non-HDL-C, total cholesterol and lipid ratios in the T2DM, MetS and neither groups. Treatment effects were of similar magnitude across patient groups with both treatments, except triglycerides, which were slightly greater in the T2DM and MetS groups vs. neither group. Changes in HDL-C , Apo A-I and high sensitivity C-reactive protein (hs-CRP) were comparable for both treatments in all three groups. Safety and tolerability profiles were generally similar between treatments and across patient groups, as were the incidence of liver and muscle AEs. Conclusions: Compared with doubling atorvastatin to 80 mg, addition of ezetimibe to atorvastatin 40 mg produced greater improvements in multiple lipid parameters in high-CHD risk patients with T2DM, MetS or neither, consistent with the significantly greater changes observed in the full study cohort (clinical trial # NCT00276484)." @default.
• W2020158846 created "2016-06-24" @default.
• W2020158846 creator A5009971196 @default.
• W2020158846 creator A5042901903 @default.
• W2020158846 creator A5048568856 @default.
• W2020158846 creator A5053191013 @default.
• W2020158846 creator A5077955682 @default.
• W2020158846 creator A5080414941 @default.
• W2020158846 creator A5081512523 @default.
• W2020158846 creator A5090460841 @default.
• W2020158846 date "2010-03-01" @default.
• W2020158846 modified "2023-10-18" @default.
• W2020158846 title "Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither" @default.
• W2020158846 cites W1969054950 @default.
• W2020158846 cites W1976212953 @default.
• W2020158846 cites W1981798840 @default.
• W2020158846 cites W1985349681 @default.
• W2020158846 cites W1987507883 @default.
• W2020158846 cites W1996755250 @default.
• W2020158846 cites W2001375687 @default.
• W2020158846 cites W2002240714 @default.
• W2020158846 cites W2015503831 @default.
• W2020158846 cites W2019834813 @default.
• W2020158846 cites W2024334311 @default.
• W2020158846 cites W2028053287 @default.
• W2020158846 cites W2028219942 @default.
• W2020158846 cites W2037251934 @default.
• W2020158846 cites W2049092532 @default.
• W2020158846 cites W2071073097 @default.
• W2020158846 cites W2094910754 @default.
• W2020158846 cites W2103714496 @default.
• W2020158846 cites W2104058454 @default.
• W2020158846 cites W2111385165 @default.
• W2020158846 cites W2123793996 @default.
• W2020158846 cites W2126477578 @default.
• W2020158846 cites W2130813021 @default.
• W2020158846 cites W2132211266 @default.
• W2020158846 cites W2136202715 @default.
• W2020158846 cites W2140072878 @default.
• W2020158846 cites W2144692487 @default.
• W2020158846 cites W2144790234 @default.
• W2020158846 cites W2154863934 @default.
• W2020158846 cites W2163092745 @default.
• W2020158846 cites W2172116397 @default.
• W2020158846 cites W4205288846 @default.
• W2020158846 cites W4211262075 @default.
• W2020158846 cites W4238251256 @default.
• W2020158846 cites W4240735590 @default.
• W2020158846 cites W74340591 @default.
• W2020158846 doi "https://doi.org/10.1111/j.1463-1326.2009.01152.x" @default.
• W2020158846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20151997" @default.
• W2020158846 hasPublicationYear "2010" @default.
• W2020158846 type Work @default.
• W2020158846 sameAs 2020158846 @default.
• W2020158846 citedByCount "34" @default.
• W2020158846 countsByYear W20201588462012 @default.
• W2020158846 countsByYear W20201588462013 @default.
• W2020158846 countsByYear W20201588462014 @default.
• W2020158846 countsByYear W20201588462015 @default.
• W2020158846 countsByYear W20201588462018 @default.
• W2020158846 countsByYear W20201588462019 @default.
• W2020158846 countsByYear W20201588462022 @default.
• W2020158846 countsByYear W20201588462023 @default.
• W2020158846 crossrefType "journal-article" @default.
• W2020158846 hasAuthorship W2020158846A5009971196 @default.
• W2020158846 hasAuthorship W2020158846A5042901903 @default.
• W2020158846 hasAuthorship W2020158846A5048568856 @default.
• W2020158846 hasAuthorship W2020158846A5053191013 @default.
• W2020158846 hasAuthorship W2020158846A5077955682 @default.
• W2020158846 hasAuthorship W2020158846A5080414941 @default.
• W2020158846 hasAuthorship W2020158846A5081512523 @default.
• W2020158846 hasAuthorship W2020158846A5090460841 @default.
• W2020158846 hasConcept C126322002 @default.
• W2020158846 hasConcept C134018914 @default.
• W2020158846 hasConcept C197934379 @default.
• W2020158846 hasConcept C2777180221 @default.
• W2020158846 hasConcept C2777482532 @default.
• W2020158846 hasConcept C2777698277 @default.
• W2020158846 hasConcept C2778096610 @default.
• W2020158846 hasConcept C2778163477 @default.
• W2020158846 hasConcept C2778375690 @default.
• W2020158846 hasConcept C2778402494 @default.
• W2020158846 hasConcept C2778657065 @default.
• W2020158846 hasConcept C2780578515 @default.
• W2020158846 hasConcept C2910068830 @default.
• W2020158846 hasConcept C500558357 @default.
• W2020158846 hasConcept C555293320 @default.
• W2020158846 hasConcept C71924100 @default.
• W2020158846 hasConcept C90924648 @default.
• W2020158846 hasConcept C98274493 @default.
• W2020158846 hasConceptScore W2020158846C126322002 @default.
• W2020158846 hasConceptScore W2020158846C134018914 @default.
• W2020158846 hasConceptScore W2020158846C197934379 @default.
• W2020158846 hasConceptScore W2020158846C2777180221 @default.
• W2020158846 hasConceptScore W2020158846C2777482532 @default.
• W2020158846 hasConceptScore W2020158846C2777698277 @default.
• W2020158846 hasConceptScore W2020158846C2778096610 @default.
• W2020158846 hasConceptScore W2020158846C2778163477 @default.

• next